R.E. Spier

2.8k total citations
107 papers, 1.8k citations indexed

About

R.E. Spier is a scholar working on Molecular Biology, Biomedical Engineering and Health. According to data from OpenAlex, R.E. Spier has authored 107 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 19 papers in Biomedical Engineering and 14 papers in Health. Recurrent topics in R.E. Spier's work include Viral Infectious Diseases and Gene Expression in Insects (34 papers), 3D Printing in Biomedical Research (14 papers) and Vaccine Coverage and Hesitancy (14 papers). R.E. Spier is often cited by papers focused on Viral Infectious Diseases and Gene Expression in Insects (34 papers), 3D Printing in Biomedical Research (14 papers) and Vaccine Coverage and Hesitancy (14 papers). R.E. Spier collaborates with scholars based in United Kingdom, United States and Israel. R.E. Spier's co-authors include A. Handa‐Corrigan, Katherine A. Kentistou, J. B. Griffiths, Michael Butler, John Clarke, W. Berthold, N.F. Kirkby, P. M. Hayter, C. MacDonald and A. Kadouri and has published in prestigious journals such as Nature, Science and FEBS Letters.

In The Last Decade

R.E. Spier

103 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R.E. Spier United Kingdom 23 1.0k 493 236 182 159 107 1.8k
Craig Cummings United States 32 971 0.9× 268 0.5× 384 1.6× 429 2.4× 477 3.0× 52 3.3k
Thean‐Hock Tang Malaysia 26 1.8k 1.8× 850 1.7× 83 0.4× 335 1.8× 255 1.6× 64 2.6k
Chintamani D. Atreya United States 28 955 0.9× 115 0.2× 187 0.8× 320 1.8× 305 1.9× 89 2.7k
Ming Yang China 21 854 0.8× 101 0.2× 120 0.5× 363 2.0× 231 1.5× 132 1.9k
Sagar B. Kudchodkar United States 27 773 0.7× 480 1.0× 177 0.8× 473 2.6× 640 4.0× 45 2.8k
Shigetoshi Eda United States 27 733 0.7× 614 1.2× 107 0.5× 312 1.7× 592 3.7× 89 2.4k
Joëlle V. Fritz Luxembourg 20 1.1k 1.0× 430 0.9× 108 0.5× 277 1.5× 234 1.5× 26 2.0k
N. H. AXELSEN Denmark 30 752 0.7× 149 0.3× 142 0.6× 655 3.6× 601 3.8× 70 2.5k
Robert J. Zagursky United States 18 1.8k 1.7× 167 0.3× 598 2.5× 632 3.5× 504 3.2× 33 3.1k
Florigio Lista Italy 27 988 0.9× 530 1.1× 183 0.8× 632 3.5× 201 1.3× 96 2.3k

Countries citing papers authored by R.E. Spier

Since Specialization
Citations

This map shows the geographic impact of R.E. Spier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.E. Spier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.E. Spier more than expected).

Fields of papers citing papers by R.E. Spier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.E. Spier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.E. Spier. The network helps show where R.E. Spier may publish in the future.

Co-authorship network of co-authors of R.E. Spier

This figure shows the co-authorship network connecting the top 25 collaborators of R.E. Spier. A scholar is included among the top collaborators of R.E. Spier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.E. Spier. R.E. Spier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spier, R.E.. (2004). Placebo: Its action and place in health research today* — Summary and conclusions. Science and Engineering Ethics. 10(1). 189–197. 1 indexed citations
2.
Spier, R.E.. (2004). Human genetic testing under examination by the European Union. Science and Engineering Ethics. 10(3). 579–586. 1 indexed citations
3.
Spier, R.E.. (2004). Ethical aspects of the methods used to evaluate the safety of vaccines. Vaccine. 22(15-16). 2085–2090. 7 indexed citations
4.
Spier, R.E.. (2000). Yeast as a Cell Factory. Enzyme and Microbial Technology. 26(9-10). 639–639. 2 indexed citations
5.
Spier, R.E.. (1999). The public understanding of vaccination. Vaccine. 17(5). 403–405. 3 indexed citations
6.
7.
Spier, R.E.. (1998). Ethical aspects of vaccines and vaccination. Vaccine. 16(19). 1788–1794. 11 indexed citations
8.
Spier, R.E.. (1997). Factors limiting the commercial application of animal cells in culture. Cytotechnology. 23(1-3). 113–117. 3 indexed citations
9.
Kadouri, A. & R.E. Spier. (1997). Some myths and messages concerning the batch and continuous culture of animal cells. Cytotechnology. 24(2). 89–98. 22 indexed citations
10.
Rumpelt, H. J., et al.. (1996). Localized Amyloid in the Menisci of the Knee Joint. Pathology - Research and Practice. 192(6). 547–551. 5 indexed citations
11.
Spier, R.E.. (1996). Ethics as a control system component. Science and Engineering Ethics. 2(3). 259–262. 3 indexed citations
12.
13.
Spier, R.E., J. B. Griffiths, & W. Berthold. (1994). Animal cell technology : products of today, prospects for tomorrow. Butterworth-Heinemann eBooks. 60 indexed citations
14.
Bushell, Michael E., et al.. (1994). Enhancement of monoclonal antibody yield by hybridoma fed‐batch culture, resulting in extended maintenance of viable cell population. Biotechnology and Bioengineering. 44(9). 1099–1106. 20 indexed citations
15.
16.
Bushell, Michael E., et al.. (1993). A three‐phase pattern in growth, monoclonal antibody production, and metabolite exchange in a hybridoma bioreactor culture. Biotechnology and Bioengineering. 42(1). 133–139. 15 indexed citations
17.
Spier, R.E., J. B. Griffiths, & C. MacDonald. (1992). Animal cell technology : developments, processes, and products. Butterworth-Heinemann eBooks. 55 indexed citations
18.
Spier, R.E., et al.. (1990). Methods for the estimation of the number and quality of animal cells immobilized in carbohydrate gels. Enzyme and Microbial Technology. 12(6). 459–463. 8 indexed citations
19.
Spier, R.E.. (1988). Veterinary vaccines: From plagues to percentages. Journal of Comparative Pathology. 99(2). 121–131. 1 indexed citations
20.
Spier, R.E., et al.. (1983). [Treatment of uninfected pseudarthroses of the lower extremity near the joint using the Küntscher medullary nail].. PubMed. 13(1). 1–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Craig Cummings Breakdown of academic impact, for papers by Thean‐Hock Tang Breakdown of academic impact, for papers by Chintamani D. Atreya Breakdown of academic impact, for papers by Ming Yang Breakdown of academic impact, for papers by Sagar B. Kudchodkar Breakdown of academic impact, for papers by Shigetoshi Eda Breakdown of academic impact, for papers by Joëlle V. Fritz Breakdown of academic impact, for papers by N. H. AXELSEN Breakdown of academic impact, for papers by Robert J. Zagursky Breakdown of academic impact, for papers by Florigio Lista
Rankless by CCL
2026